Mode
Text Size
Log in / Sign up
N/A N=2,108 Other

Worksite Lifestyle Program for Reducing Diabetes and Cardiovascular Risk in India

Diabetes · Heart Disease · Obesity

Enrolled (actual)
2,108
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcome: Primary: Number of Participants Reaching Two or More Cardiometabolic Risk Goals — 485; 351 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Lifestyle Intervention Training Program (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Emory University
Primary completion
Jan 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Reaching Two or More Cardiometabolic Risk Goals
485; 351
SECONDARY
Blood Pressure (BP)
132.28; 127; 128.4; 85.21; 83.6; 83.8
SECONDARY
Mean Hemoglobin A1c (HbA1c) Level
6.41; 6.1; 6.3
SECONDARY
Number of New Diabetes Cases
660; 481
SECONDARY
Mean Fasting Plasma Glucose
105.80; 108.6; 113.6
SECONDARY
Mean Body Mass Index (BMI)
27.35; 27.2; 27.1
SECONDARY
Mean Body Weight
74.2; 73.4; 72.7
SECONDARY
Waist Circumference
95.5; 93.7; 94.0
SECONDARY
Number of Patients Overweight or Obese
639; 653; 604; 863; 604; 524
SECONDARY
Prevalence of Hypertension
388; 307; 68; 13; 357; 280
SECONDARY
Mean Triglycerides Level
140.58; 148.8; 155.8
SECONDARY
Mean Low Density Lipoprotein (LDL)
117.0; 119.0; 121.6
SECONDARY
Mean High Density Lipoprotein (HDL)
43.54; 44.2; 43.9
SECONDARY
Number of Patients With Prediabetes or Newly Detected Diabetes That Achieve Normoglycemia Rates
330

Summary

This study will test the implementation, effectiveness, cost-effectiveness, and acceptability of a worksite lifestyle improvement program that includes lifestyle education classes led by trained individuals from the worksite and improvements in the worksite environment that will make it easier for employees at risk for diabetes or with unmedicated diabetes to lose weight, exercise more, and eat a healthier diet. A total of 2000 participants across 10 worksites in South, Central, and East India will be involved in this study.

Eligibility Criteria

Inclusion Criteria

  • BMI ≥23 kg/m2 and/or waist circumference ≥90 cm for men and ≥80 cm for women
  • Prediabetic (HbA1c of 5.7-6.4%) or diabetic (HbA1c≥6.5%)

Exclusion Criteria

  • Currently taking any diabetes medications
  • Pregnant or breastfeeding
  • History of heart disease, current serious illness, or conditions which would impede participation in an unsupervised physical activity and diet change program
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02813668). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search